Target intelligence / Profile preview

Neuroimmune and exosome-responsive pathways

Molecular classification
Other
01

Overview

Neuroimmune and exosome-responsive pathways represent a complex network of interactions between the central nervous system and the immune system, primarily mediated by extracellular vesicles known as exosomes (PubMed: 30214430). These pathways are not characterized by a single molecular target but involve the collective action of proteins, lipids, and nucleic acids—such as microRNAs—transported within exosomes to modulate neuroinflammatory responses and promote tissue repair (PubMed: 31607530). In the context of neurodegenerative diseases like Alzheimer's or Multiple Sclerosis, these pathways play a critical role in regulating microglia activation and neuronal survival (PubMed: 33072175). Therapeutic strategies targeting these pathways often utilize stem cell-derived exosomes to deliver anti-inflammatory signals across the blood-brain barrier, offering a multifaceted approach to neuroprotection (PubMed: 32831118). Because of the heterogeneous nature of these pathways, they are frequently used as a descriptive category for complex biologics where the exact mechanism of action involves multiple signaling cascades rather than a single receptor-ligand interaction.

Other names
Neuroimmune signaling axisExosome-mediated neuroimmunomodulationExtracellular vesicle-responsive pathwaysNeuroinflammatory signaling networks
02

Mechanism of action

Modulation of the neuroinflammatory environment through the paracrine delivery of bioactive cargo, including microRNAs, proteins, and lipids, which alter the activation state of microglia and astrocytes (PubMed: 30214430).

03

Biological functions

Immune responseSignal transductionCell-cell communicationNeuroinflammationSynaptic plasticity
04

Disease associations

Neurodegenerative diseaseMultiple sclerosisAlzheimer's diseaseTraumatic brain injuryStrokeInflammation
05

Safety considerations

Product heterogeneity and batch-to-batch variabilityPotential for unintended systemic immune activationDifficulty in standardizing isolation and characterization protocolsUnknown long-term effects of exosomal cargo on genomic stability
06

Interacting drugs

Mesenchymal stem cell-derived exosomes (MSC-Exos)

2 more in the full profile.

07

Biomarkers

Exosomal microRNA (e.g., miR-124, miR-146a)Pro-inflammatory cytokines (TNF-alpha, IL-6)Glial fibrillary acidic protein (GFAP)Triggering receptor expressed on myeloid cells 2 (TREM2)

Beyond the preview

Go deeper on Neuroimmune and exosome-responsive pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroimmune and exosome-responsive pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call